Detailed answers about GRADIENT HEALTH ANALYTICS LTD, including incorporation, status, business activity, and accounts information.
When was GRADIENT HEALTH ANALYTICS LTD founded?
GRADIENT HEALTH ANALYTICS LTD was officially incorporated on 30 December 2020 and is registered under company number 13104605. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GRADIENT HEALTH ANALYTICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GRADIENT HEALTH ANALYTICS LTD?
GRADIENT HEALTH ANALYTICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GRADIENT HEALTH ANALYTICS LTD do?
GRADIENT HEALTH ANALYTICS LTD operates in the following sectors: 71200 - Technical testing and analysis, 72110 - Research and experimental development on biotechnology, 72200 - Research and experimental development on social sciences and humanities, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is GRADIENT HEALTH ANALYTICS LTD's registered address?
The registered office address of GRADIENT HEALTH ANALYTICS LTD is 68 BROOKLYN AVENUE, LOUGHTON, ENGLAND, IG10 1BN. This is the official address filed with Companies House for legal and statutory correspondence.
Is GRADIENT HEALTH ANALYTICS LTD financially stable?
The most recent accounts for GRADIENT HEALTH ANALYTICS LTD were made up to 31 December 2024, filed as MICRO ENTITY. Next accounts are due by 30 September 2026.